MORGAN STANLEY PLC/CALL/NOVO NORDISK ADR B/210/0.1/21.03.25 | Market Closed - Börse Stuttgart 12:58:11 29/06/2024 am IST | ||
| 0.236 EUR | -1.67% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 0.236 | -1.67% |
| 27/24/27 | 0.24 | -7.69% |
| 26/24/26 | 0.26 | -13.33% |
| 25/24/25 | 0.3 | +32.16% |
| 24/24/24 | 0.227 | -4.62% |
Delayed Quote Börse Stuttgart
Last update June 29, 2024 at 12:58 am IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | Morgan Stanley |
| WKN | MG5D29 |
| ISIN | DE000MG5D291 |
| Date issued | 06/06/2024 |
| Strike | 210 $ |
| Maturity | 21/03/2025 (265 Days) |
| Parity | 10 : 1 |
| Emission price | 0.26 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.31 € |
|---|---|
| Lowest since issue | 0.199 € |
| Delta | 0.14x |
| Omega | 7.797 |
| Premium | 48.88x |
| Gearing | 56.71x |
| Moneyness | 0.6797 |
| Difference Strike | 67.26 $ |
| Difference Strike % | +32.03% |
| Spread | 0.006 € |
| Spread % | 2.52% |
| Theoretical value | 0.2350 |
| Implied Volatility | 33.34 % |
| Total Loss Probability | 91.52 % |
| Intrinsic value | 0.000000 |
| Present value | 0.2350 |
| Break even | 212.52 € |
| Theta | -0.01x |
| Vega | 0.02x |
| Rho | 0.01x |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,006
DKK
Average target price
949.7
DKK
Spread / Average Target
-5.56%
- Stock Market
- Warrants
- Warrant
